GeneDx Holdings Corp.
WGS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $428M | $305M | +40.0% |
| Operating income | −$13.1M | −$23.2M | +43.6% |
| Net income | −$21.0M | −$52.3M | +59.8% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $123M | $117M | +5.5% |
| Operating income | −$10.4M | −$3.30M | −215% |
| Net income | −$12.3M | −$7.60M | −61.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was GeneDx's revenue in FY2025?
- $428M in FY2025 (Fiscal year ended Dec 31, 2025), +40.0% vs $305M a year earlier, per its 10-K filed Feb 2026.
- Was GeneDx profitable in FY2025?
- No: net income was −$21.0M and operating income −$13.1M in FY2025.
- What was GeneDx's revenue in Q3 2026?
- $123M (+5.5% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.